Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | CITRATE (CAS# 77-92-9); (M-H)- | 8475834 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | CITRATE (CAS# 77-92-9); (M-H)- | 9451944 | Peak area | BS4 | Untreated |
Reversed phase NEGATIVE ION MODE | CITRATE (CAS# 77-92-9); (M-H)- | 10900000 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | CITRATE (CAS# 77-92-9); (M-H)- | 10900000 | Peak area | HAHA | TNF-alpha |
Reversed phase NEGATIVE ION MODE | CITRATE (CAS# 77-92-9); (M-H)- | 11600000 | Peak area | BS4 | TNF-alpha |
Reversed phase NEGATIVE ION MODE | CITRATE (CAS# 77-92-9); (M-H)- | 11600000 | Peak area | HAHA | IL-17A |
Reversed phase NEGATIVE ION MODE | CITRATE (CAS# 77-92-9); (M-H)- | 11600000 | Peak area | PAK | IFN-G |
Reversed phase NEGATIVE ION MODE | CITRATE (CAS# 77-92-9); (M-H)- | 12000000 | Peak area | PAK | TNF-alpha |
Reversed phase NEGATIVE ION MODE | CITRATE (CAS# 77-92-9); (M-H)- | 12100000 | Peak area | PAK | IL-17A |
Reversed phase NEGATIVE ION MODE | CITRATE (CAS# 77-92-9); (M-H)- | 12200000 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | CITRATE (CAS# 77-92-9); (M-H)- | 12500000 | Peak area | PAK | Untreated |
Reversed phase NEGATIVE ION MODE | CITRATE (CAS# 77-92-9); (M-H)- | 13300000 | Peak area | HAHA | IFN-G |
Reversed phase NEGATIVE ION MODE | CITRATE (CAS# 77-92-9); (M-H)- | 13900000 | Peak area | BS4 | IFN-G |
Reversed phase NEGATIVE ION MODE | CITRATE (CAS# 77-92-9); (M-H)- | 14800000 | Peak area | HAHA | Untreated |
Reversed phase NEGATIVE ION MODE | CITRATE (CAS# 77-92-9); (M-H)- | 15200000 | Peak area | BS4 | IL-17A |
Reversed phase POSITIVE ION MODE | CITRATE (CAS# 77-92-9); (M+NA)+ | 21157 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | CITRATE (CAS# 77-92-9); (M+NA)+ | 22124 | Peak area | PAK | TNF-alpha |
Reversed phase POSITIVE ION MODE | CITRATE (CAS# 77-92-9); (M+NA)+ | 24324 | Peak area | PAK | Untreated |
Reversed phase POSITIVE ION MODE | CITRATE (CAS# 77-92-9); (M+NA)+ | 25785 | Peak area | BS4 | TNF-alpha |
Reversed phase POSITIVE ION MODE | CITRATE (CAS# 77-92-9); (M+NA)+ | 26676 | Peak area | PAK | IFN-G |
Reversed phase POSITIVE ION MODE | CITRATE (CAS# 77-92-9); (M+NA)+ | 27178 | Peak area | BS4 | Untreated |
Reversed phase POSITIVE ION MODE | CITRATE (CAS# 77-92-9); (M+NA)+ | 28255 | Peak area | HAHA | IL-17A |
Reversed phase POSITIVE ION MODE | CITRATE (CAS# 77-92-9); (M+NA)+ | 28510 | Peak area | PAK | IL-17A |
Reversed phase POSITIVE ION MODE | CITRATE (CAS# 77-92-9); (M+NA)+ | 28828 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | CITRATE (CAS# 77-92-9); (M+NA)+ | 31324 | Peak area | HAHA | IFN-G |
Reversed phase POSITIVE ION MODE | CITRATE (CAS# 77-92-9); (M+NA)+ | 32446 | Peak area | BS4 | IL-17A |
Reversed phase POSITIVE ION MODE | CITRATE (CAS# 77-92-9); (M+NA)+ | 35478 | Peak area | BS4 | IFN-G |
Reversed phase POSITIVE ION MODE | CITRATE (CAS# 77-92-9); (M+NA)+ | 35507 | Peak area | HAHA | TNF-alpha |
Reversed phase POSITIVE ION MODE | CITRATE (CAS# 77-92-9); (M+NA)+ | 38435 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | CITRATE (CAS# 77-92-9); (M+NA)+ | 39460 | Peak area | HAHA | Untreated |